rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2006-7-13
|
pubmed:abstractText |
The success rate of pharmacological cardioversion of atrial fibrillation (AF) in patients depends on the duration of AF. It is unknown to what extent AF-induced structural atrial remodeling contributes to this loss of efficacy.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1045-3873
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
648-54
|
pubmed:meshHeading |
pubmed-meshheading:16836716-Action Potentials,
pubmed-meshheading:16836716-Animals,
pubmed-meshheading:16836716-Anti-Arrhythmia Agents,
pubmed-meshheading:16836716-Atrial Fibrillation,
pubmed-meshheading:16836716-Dose-Response Relationship, Drug,
pubmed-meshheading:16836716-Electrocardiography,
pubmed-meshheading:16836716-Female,
pubmed-meshheading:16836716-Flecainide,
pubmed-meshheading:16836716-Goats,
pubmed-meshheading:16836716-Heart Conduction System,
pubmed-meshheading:16836716-Imidazoles,
pubmed-meshheading:16836716-Time Factors
|
pubmed:year |
2006
|
pubmed:articleTitle |
Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
|
pubmed:affiliation |
Department of Physiology, Cardiovascular Research Institute Maastricht (CARIM)Maastricht University, the Netherlands.
|
pubmed:publicationType |
Journal Article
|